Greenville, MS4 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Greenville, MS

Find 4 actively recruiting myalgic encephalomyelitis clinical trials in Greenville, MS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
767
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Greenville

About Myalgic Encephalomyelitis Clinical Trials in Greenville

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 4 myalgic encephalomyelitis clinical trials recruiting participants in Greenville, MS. These studies are seeking a combined 767 participants. Research is being sponsored by Takeda, Biogen, University of Texas Southwestern Medical Center and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Greenville — FAQ

Are there myalgic encephalomyelitis clinical trials in Greenville?

Yes, there are 4 myalgic encephalomyelitis clinical trials currently recruiting in Greenville, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 4 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov